Avantor, Inc.
AVTR
NYSE·Healthcare·Medical - Instruments & Supplies·Mkt cap $9.9B
$14.61
▲ +0.76%
P/E
117.92
Mkt Cap
$9.9B
52-Wk Range
$7.27–$15.93
52-Week Range
$7.27 - $15.93
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 10.8% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
1 risk
- Average volatility.
Growth
Strong growth ahead
Value
Attractively priced below sector peer average
Momentum
Hot
+73.9% over 3m
Quality
Stable
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying AVTR right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 4, 2026
JUL 29, 2026
Reported EPS of $0.21 vs $0.19 consensus (+9.7% surprise). Revenue of $1.7B vs $1.6B expected (+5.1%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+9.7%
Revenue trend · last 2Q
—
+1%
Q1 26
Q2 26
$1.6B
$1.7B
Margins · last 2Q
Gross
31.7%
Operating
7.2%
Profit
2.3%
Wall Street consensus
7 analysts · 0% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
0%
Hold
86%
Sell
14%
Median Price Target
$7.00
▼ -52.1% vs $14.61
Latest: RBC Capital · Jul 30, 2026
1 analyst covering
vs Industry
How AVTR stacks vs Medical - Instruments & Supplies
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.